Study supports early use of antifungal therapy in NICU babies

04/6/2012 | Medscape (free registration)

Empiric antifungal therapy should be considered before blood culture results are available for extremely low birth weight babies at high risk of invasive Candida to help prevent death or neurodevelopmental impairment, researchers reported in The Journal of Pediatrics. Duke University researchers said Candida species are a leading cause of death in NICUs and waiting for blood culture results could take days and have fatal consequences.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN